Pennant Current Ratio 2018-2026 | PNTG
Pennant current ratio from 2018 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Pennant Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-03-31 | $0.15B | $0.13B | 1.19 |
| 2025-12-31 | $0.17B | $0.15B | 1.14 |
| 2025-09-30 | $0.11B | $0.11B | 1.04 |
| 2025-06-30 | $0.13B | $0.11B | 1.21 |
| 2025-03-31 | $0.12B | $0.09B | 1.41 |
| 2024-12-31 | $0.12B | $0.10B | 1.21 |
| 2024-09-30 | $0.10B | $0.09B | 1.12 |
| 2024-06-30 | $0.09B | $0.08B | 1.13 |
| 2024-03-31 | $0.09B | $0.08B | 1.16 |
| 2023-12-31 | $0.08B | $0.07B | 1.12 |
| 2023-09-30 | $0.07B | $0.07B | 1.05 |
| 2023-06-30 | $0.07B | $0.07B | 1.05 |
| 2023-03-31 | $0.07B | $0.07B | 1.02 |
| 2022-12-31 | $0.07B | $0.07B | 1.05 |
| 2022-09-30 | $0.07B | $0.07B | 0.92 |
| 2022-06-30 | $0.08B | $0.08B | 1.00 |
| 2022-03-31 | $0.08B | $0.07B | 1.19 |
| 2021-12-31 | $0.08B | $0.07B | 1.06 |
| 2021-09-30 | $0.08B | $0.08B | 0.98 |
| 2021-06-30 | $0.07B | $0.08B | 0.89 |
| 2021-03-31 | $0.07B | $0.09B | 0.81 |
| 2020-12-31 | $0.06B | $0.09B | 0.67 |
| 2020-09-30 | $0.05B | $0.08B | 0.64 |
| 2020-06-30 | $0.05B | $0.08B | 0.65 |
| 2020-03-31 | $0.05B | $0.05B | 0.94 |
| 2019-12-31 | $0.04B | $0.05B | 0.76 |
| 2019-09-30 | $0.03B | $0.05B | 0.67 |
| 2019-06-30 | $0.00B | 0.00 | |
| 2019-03-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.00B | 0.00 | |
| 2017-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.072B | $0.948B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |